Xponance’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.8M Buy
239,762
+5,221
+2% +$421K 0.12% 133
2026
Q1
$20.3M Buy
234,541
+29,695
+14% +$2.84M 0.14% 112
2025
Q4
$19.7M Sell
204,846
-1,082
-0.5% -$105K 0.15% 104
2025
Q3
$19.6M Sell
205,928
-8,731
-4% -$803K 0.16% 99
2025
Q2
$18.7M Buy
214,659
+27,030
+14% +$2.29M 0.16% 104
2025
Q1
$16.9M Sell
187,629
-872
-0.5% -$78K 0.16% 103
2024
Q4
$15.1M Buy
188,501
+6,222
+3% +$539K 0.14% 116
2024
Q3
$16.4M Sell
182,279
-2,381
-1% -$200K 0.16% 103
2024
Q2
$14.5M Sell
184,660
-3,982
-2% -$326K 0.15% 110
2024
Q1
$16.4M Buy
188,642
+13,930
+8% +$1.19M 0.17% 104
2023
Q4
$14.4M Buy
174,712
+10,461
+6% +$797K 0.17% 102
2023
Q3
$12.9M Buy
164,251
+4,848
+3% +$406K 0.18% 97
2023
Q2
$14M Sell
159,403
-18,548
-10% -$1.6M 0.19% 96
2023
Q1
$14.3M Buy
177,951
+5,305
+3% +$432K 0.21% 88
2022
Q4
$13.4M Buy
172,646
+27,574
+19% +$2.23M 0.22% 93
2022
Q3
$11.7M Buy
145,072
+37,715
+35% +$3.39M 0.23% 80
2022
Q2
$9.63M Buy
107,357
+18,129
+20% +$1.84M 0.19% 97
2022
Q1
$9.9M Buy
89,228
+3,141
+4% +$332K 0.16% 107
2021
Q4
$8.91M Buy
86,087
+18,037
+27% +$2.09M 0.14% 129
2021
Q3
$8.53M Sell
68,050
-35,017
-34% -$4.53M 0.16% 113
2021
Q2
$12.8M Sell
103,067
-25,016
-20% -$3.14M 0.24% 74
2021
Q1
$15.1M Sell
128,083
-133
-0.1% -$15.6K 0.32% 59
2020
Q4
$15M Buy
128,216
+689
+0.5% +$75.8K 0.33% 56
2020
Q3
$13.3M Buy
127,527
+22,045
+21% +$2.21M 0.33% 57
2020
Q2
$9.67M Buy
+105,482
New +$10.1M 0.25% 84

Other funds holding MDT

Xponance's MDT Position: Q2 2026 in Review

Xponance increased its Medtronic (MDT) stake by 2.2% in Q2 2026, buying an estimated $421K and bringing the position to 239,762 shares worth $18.8M. The position accounts for 0.12% of the portfolio, ranked #133.

Xponance first reported a position in MDT in Q2 2020 and has held it in 25 quarters since. The position peaked at $20.3M in Q1 2026. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Xponance held 239,762 shares of Medtronic worth $18.8M as of Q2 2026.
  • Xponance bought 5,221 Medtronic shares in Q2 2026, an estimated $421K.
  • Medtronic made up 0.12% of Xponance's portfolio in Q2 2026, its #133 holding.
  • Xponance first reported a position in Medtronic in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Medtronic position peaked at $20.3M in Q1 2026.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.